(Ancillary Services Offered by Treatment Facilities in the US, 2012)

(Ancillary Services Provided by Treatment Facilities, 2007) "One or more of the 17 specified ancillary services were provided by 99 percent of all facilities (Table 1). Ancillary services provided by more than half of all facilities included substance abuse education (94 percent); case management services (76 percent); social skills development (66 percent); HIV or AIDS education, counseling, or support (56 percent); mental health services (54 percent); and assistance with obtaining social services (52 percent)."

(Patient Response To Computerized Treatment Versus Therapist-Delivered Therapy) "Results: Compared with computer- or therapist-delivered CBT/MI [cognitive behaviour therapy and motivational interviewing], PCT [person-centred therapy] was associated with significantly less reduction in depression and alcohol consumption at 3 months. CAC [(clinician-assisted computerised] therapy was associated with improvement at least equivalent to that achieved by therapist-delivered treatment, with superior results as far as reducing alcohol consumption.

(Women Under-Represented in Substance Use Treatment Globally) "To be equally represented in treatment, the ratio of males to females in treatment should be similar to the ratio of males to females in problem drug use. Using past-month prevalence as a proxy for problematic use,²⁴ gender-disaggregated data from EMCDDA on past-month prevalence and outpatient clients in treatment suggest that in most countries in Europe females could be underrepresented in treatment for the problematic use of cannabis, cocaine and amphetamines (see figure 5).

(Worldwide Treatment Need, by Substance, 2010) "It is estimated that 20 per cent of problem drug users in 2010 received treatment for their drug dependence. Opioids (largely heroin) continue to be the dominant drug type accounting for treatment demand in Asia and Europe (particularly in Eastern Europe and South-Eastern Europe, where they account for almost four out of every five drug users in treatment). Opioids also contribute considerably to demand for treatment in Africa, North America and Oceania.

(Marijuana-Involved Admissions to Treatment in the US, 1999-2009) "An admission [to treatment] was considered marijuana-involved if marijuana was reported as a primary, secondary, or tertiary substance. In 1999, 43 percent of all adolescent admissions were marijuana-involved admissions referred to treatment by the criminal justice system, and 39 percent were marijuana involved but referred by other sources.

(Admissions to Treatment for Alcohol with Secondary Drug Use in the US, 2012)
"• Admissions for primary abuse of alcohol with secondary abuse of drugs represented 18 percent of TEDS admissions aged 12 and older in 2012 [Table 1.1b].
"• The average age at admission for primary alcohol with secondary drug abuse was lower, at 37 years, than for abuse of alcohol alone (41 years) [Table 2.1a].

(Types of Treatment) "Currently, pharmaceutical treatment for substance abuse addiction in the United States is limited to two basic types: (1) replacement therapy; and (2) aversion therapy.²¹ Replacement therapy is characterized by substituting or replacing the drug that the person is addicted to with a “safer drug” under the theory that the individual can be weaned off the replacement drug over time.²² The most prominent examples of this are methadone maintenance for heroin addiction and nicotine replacement drugs for smokers.²³

(Admissions to Treatment for Primary Alcohol Abuse Alone, in the US, 2012)
"• Admissions for abuse of alcohol alone, with no secondary drug abuse, represented 21 percent of TEDS admissions aged 12 and older in 2012 [Table 1.1b].
"• The average age at admission among admissions for alcohol only was 41 years. The average age at admission for alcohol with secondary drug was 37 years [Table 2.1a]. Admission for alcohol only or with secondary drug was the most likely reason for admissions aged 30 and older [Table 2.1b].